Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study.|https://dx.doi.org/10.1111/imj.70057
Subgroup analyses in randomized trials of Clostridioides difficile associated disease: Recurring Challenges with Analyzing Recurrence.|https://dx.doi.org/10.1093/cid/ciaf188
Healthcare-Associated Infections: The Role of Microbial and Environmental Factors in Infection Control-A Narrative Review.|https://dx.doi.org/10.1007/s40121-025-01143-0
Integrating Clinical Guidelines With ChatGPT-4 Enhances Its' Skills.|https://dx.doi.org/10.1016/j.mcpdig.2024.02.004
Clinical translation of microbiome research.|https://dx.doi.org/10.1038/s41591-025-03615-9
RCPE in association with the American College of Gastroenterology and the Scottish Society of Gastroenterology - Gastroenterology: A global perspective.|https://dx.doi.org/10.1177/14782715251332318
Metronidazole-ursodeoxycholic acid bifunctional antibacterial: A promising strategy to combat Clostridium difficile infection and prevent recurrence.|https://dx.doi.org/10.1016/j.ejmech.2025.117631
Isolated Adult Gastrointestinal Tract Langerhans Cell Histiocytosis-Report of Two Rare Patients with Review of Literature.|https://dx.doi.org/10.1177/10668969251332307
Primary solitary pituitary stalk abscess: case report and review.|https://dx.doi.org/10.3389/fendo.2025.1510593
Extended-pulsed Fidaxomicin Therapy for Recurrent Clostridioides difficile Infection After Standard Vancomycin and Fidaxomicin Failure: A Case Report.|https://dx.doi.org/10.1016/j.jiac.2025.102709
Efficacy and Safety of Fecal Microbiota Transplant for Prevention of Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.1093/cid/ciaf142
FMT for Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.1093/cid/ciaf138
Faecal microbiota transplantation for recurrent Clostridiodes difficile infection & its global regulatory landscape.|https://dx.doi.org/10.25259/IJMR_818_2024
Management of severe and fulminant Clostridioides difficile infection in adults.|https://dx.doi.org/10.1099/jmm.0.001991
The Global Burden of Clostridioides difficile Infections, 2016-2024: A Systematic Review and Meta-Analysis.|https://dx.doi.org/10.3390/idr17020031
Anatomic Factors Influencing a Persistent J-Sign After Medial Patellofemoral Ligament Reconstruction and Distal Tibial Tubercle Osteotomy in Patients With Recurrent Patellar Dislocations and Patella Alta: A Retrospective Cohort Study.|https://dx.doi.org/10.1177/03635465251336162
Factors associated with failure of fecal microbiota transplant for recurrent Clostridioides difficile infection.|https://dx.doi.org/10.1177/17562848251334517
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA(®)) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.|https://dx.doi.org/10.1177/17562848251339697
Clinical and Microbiological Characteristics of Hospitalized Adults Aged ≤ 45 Years With Clostridioides (Formerly Clostridium) difficile Infection: A Prospective Observational Cohort Study From Hungary.|https://dx.doi.org/10.1111/apm.70028
Partial Courses of Fidaxomicin Followed by Oral Vancomycin and the Effect on Recurrence of Clostridioides difficile Infections.|https://dx.doi.org/10.1177/10600280251332946
